Wang, H., Sheehan, R. P., Palmer, A. C., Everley, R. A., Boswell, S. A., Ron-Harel, N., . . . Sorger, P. K. (2019). Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via metabolic reprogramming. Cell Syst.
シカゴスタイル引用形Wang, Huan, et al. "Adaptation of Human IPSC-derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity Via Metabolic Reprogramming." Cell Syst 2019.
MLA引用形式Wang, Huan, et al. "Adaptation of Human IPSC-derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity Via Metabolic Reprogramming." Cell Syst 2019.
警告: この引用は必ずしも正確ではありません.